Position in ALNY
as of Jun 30, 2026
· filed Jul 14, 2026
Position Value
$12,944
+$6,327 QoQ
Shares Held
43
+115.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#678
of 784 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ALNY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Cromwell Holdings LLC holds $957,383 across 23 Biotechnology names. ALNY ranks #7 (1.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
664 | $329,828 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
342 | $213,250 | |
| 3 | ARGX |
Argenx SE
|
187 | $173,492 | |
| 4 | MRNA |
Moderna, Inc.
|
1,259 | $88,167 | |
| 5 | INCY |
Incyte Corp
|
534 | $60,534 | |
| 6 | GMAB |
Genmab A/S
|
1,077 | $29,585 | |
| 7 | ALNY |
Alnylam Pharmaceuticals, Inc.
This page
|
43 | $12,944 | |
| 8 | RVMD |
Revolution Medicines, Inc.
|
41 | $7,678 |
All Filings in ALNY
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $12,944 | 43 | Shares | Sole | 2026-07-14 | |
| 2026-03-31 | $6,617 | 20 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $7,953 | 20 | Shares | Sole | 2026-01-20 | |
| 2025-09-30 | $9,120 | 20 | Shares | Sole | 2025-10-24 | |
| 2025-06-30 | $6,521 | 20 | Shares | Sole | 2025-07-21 | |
| 2025-03-31 | $1,620 | 6 | Shares | Sole | 2025-05-01 | |
| No filing history on record for this holder in this stock. | ||||||